Holen Sie sich die Stockscreener-App
1.19
4.39%
0.05
Therapeuticsmd Inc Aktie (TXMD) Neueste Nachrichten
Is TherapeuticsMD Inc. a good long term investmentHigh-yield capital appreciation - PrintWeekIndia
What analysts say about TherapeuticsMD Inc. stockFree Stock Movement Tracking - Autocar Professional
What drives TherapeuticsMD Inc. stock priceRecord-breaking gains - PrintWeekIndia
TherapeuticsMD Inc. Stock Analysis and ForecastExceptional risk-adjusted gains - Autocar Professional
How TherapeuticsMD Inc. stock performs during market volatilityFree Stock Market Analysis Courses - Newser
TherapeuticsMD (NASDAQ:TXMD) Shares Down 0.8% – What’s Next? - Defense World
What makes TherapeuticsMD Inc. stock price move sharplyIntraday Trade Ideas - Newser
Why TherapeuticsMD Inc. stock attracts strong analyst attentionMinimized Risk Maximum Return - Newser
Mayne Pharma Group Unit Seeks Over $11.5 Million in Damages in US Court Complaint Against TherapeuticsMD - marketscreener.com
Mayne Pharma Files Legal Complaint Against TherapeuticsMD - TipRanks
StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD) - Defense World
TherapeuticsMD (NASDAQ:TXMD) Now Covered by Analysts at StockNews.com - Defense World
TherapeuticsMD Reports Improved Q1 2025 Results - TipRanks
TherapeuticsMD Announces First Quarter 2025 Financial Results | - GuruFocus
TherapeuticsMD: Q1 Earnings Snapshot - CT Insider
TherapeuticsMD Announces First Quarter 2025 Financial Results - BioSpace
TherapeuticsMD Inc Reports Q1 2025 Results: EPS at -$0.06, Revenue Reaches $393K - GuruFocus
TherapeuticsMD Reports Q1 2025 Financial Results - TipRanks
TherapeuticsMD Q1 Operating Expenses USD 1.264 Million - marketscreener.com
2.82%
0.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):